ED (Erectile Dysfunction) Medicine Manufacturer

Empowering Men’s Health Worldwide

Aprazer Healthcare specializes in the manufacturing ed medicine and global distribution of affordable, effective erectile dysfunction medicines, helping more than 80% of men.

WHO–GMP and EU approved oral treatments for Premature Ejaculation (PE) and Erectile Dysfunction, two of the most common sexual health issues.

Unmasking Erectile Dysfunctions

Males are wrongly told to mask their emotions. Sexual dysfunction can significantly impact men’s quality of life, psychosocial, and psycho-sexual adjustment.

• • Relationship Issues
• • Reduced Self-Esteem
• • Anxiety and Depression
• • Withdrawal from Sexual Intimacy
• • Impact on Partner

Understanding Key Conditions

Premature Ejaculation (PE) – Ejaculation or orgasm occurring sooner than desired. Every man may experience PE at some point in life.

Erectile Dysfunction (ED) – Difficulty achieving or maintaining an erection, delaying sexual intercourse. Erectile dysfunction is on the rise and is expected to affect 325 million men globally by 2025.

Aprazer Healthcare meets the growing global demand through manufacturing, export, and supply of high-quality medicines.

Our Men’s Health Portfolio

• • Dapobest-30 – Dapoxetine, widely used for treating premature ejaculation in men aged 18 to 64.
• • Super Viabest – Combination of Dapoxetine and Sildenafil, effectively preventing premature ejaculation and erectile dysfunction.
• • Tadabest – Treats erectile dysfunction and prostate enlargement (benign prostate hyperplasia).

Aprazer Healthcare — Because Every Man Deserves a Fulfilling Life.